// App-Quantinova.ai

1065 : Biosamples from VEDOSS Patients Show Pathological Signs of SSc: Opportunity for a Biololgical Diagnosis of Disease

Researchers

Presenter

  • Rebecca Ross

Principal Investigators

  • Emily Clarke

  • Will Merchant

  • Panji Mulipa

  • Natalia Riobo-DelGaldo

  • Francesco Del Galdo

Medical Centers

  • University of Leeds, Leeds, United Kingdom

  • Leeds Institute of Rheumatic and Musculoskeletal Medicine and NIHR-Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Scleroderma

Biomarkers

  • C-C Motif Chemokine Ligand 2

  • C-X-C motif chemokine ligand 9

  • Protein Tyrosine Phosphatase, Receptor Type C

Drug/Treatment

  • IFN-lambda

Outcome

  • N/A


Study Design

  • Double Blind/Blinded

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A